Search research articles
Contact Us
Filters
Showing results (281-290 of 298) with videos related to
Page
of 30
Sort By:
American Journal of Hematology
|
April 9, 2020
Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group
Stefano Giardino, Regis P de Latour, Mahmoud Aljurf, et al.
Blood Advances
|
September 9, 2025
Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies
Michael Loschi, Marie-Charlotte Villy, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation
|
February 11, 2023
Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS
Claire Michel, Marie Robin, Stephane Morisset, et al.
American Journal of Hematology
|
May 6, 2025
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)
Yves Chalandon, Raynier Devillier, Ariane Boumendil, et al.
Archives of Cardiovascular Diseases
|
April 30, 2021
ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France
Guillaume Bonnet, Vassili Panagides, Mathieu Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 13, 2024
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)
Olivier Tournilhac, Bettina Altmann, Birte Friedrichs, et al.
Journal of Hematology & Oncology
|
January 7, 2024
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry
Claire Lacan, Jérôme Lambert, Edouard Forcade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2024
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori, Caterina Gregorio, Marie Robin, et al.
Bone Marrow Transplantation
|
April 1, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee
Christopher Armstrong, Kavita Raj, Giorgia Battipaglia, et al.
The Lancet. Haematology
|
June 4, 2026
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
Carmelo Gurnari, Chris Armstrong, Giorgia Battipaglia, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 298) with videos related to
Sort By:
Page
of 30
American Journal of Hematology
|
April 9, 2020
Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group
Stefano Giardino, Regis P de Latour, Mahmoud Aljurf, et al.
Blood Advances
|
September 9, 2025
Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies
Michael Loschi, Marie-Charlotte Villy, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation
|
February 11, 2023
Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS
Claire Michel, Marie Robin, Stephane Morisset, et al.
American Journal of Hematology
|
May 6, 2025
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)
Yves Chalandon, Raynier Devillier, Ariane Boumendil, et al.
Archives of Cardiovascular Diseases
|
April 30, 2021
ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France
Guillaume Bonnet, Vassili Panagides, Mathieu Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 13, 2024
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)
Olivier Tournilhac, Bettina Altmann, Birte Friedrichs, et al.
Journal of Hematology & Oncology
|
January 7, 2024
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry
Claire Lacan, Jérôme Lambert, Edouard Forcade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2024
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori, Caterina Gregorio, Marie Robin, et al.
Bone Marrow Transplantation
|
April 1, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee
Christopher Armstrong, Kavita Raj, Giorgia Battipaglia, et al.
The Lancet. Haematology
|
June 4, 2026
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
Carmelo Gurnari, Chris Armstrong, Giorgia Battipaglia, et al.
Page
of 30